CD8A and acute myeloid leukemia: Several groups have consistently reported that TIGIT is highly expressed on CD8+ TILs in many cancers, such as nonsmall cell lung cancer, colon cancer, melanoma [34, 79], and acute myelogenous leukemia [83].